Belgium, Mont Saint-Guibert, February 17 – Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy ...
February 17, 2025
February 5, 2025
December 3, 2024
November 21, 2024
Belgium, Mont Saint-Guibert, February 17 – Cellistic, a pioneer in iPSC-based off-the-shelf ...
December 13, 2024
Tokyo, Japan and Mont-Saint-Guibert, Belgium, – December 13th, 2024 BrightPath Bio (Tokyo ...
Belgium, Mont-Saint-Guibert, November 21, 2024 – Cellistic®, a pioneer in iPSC-based ...
October 26, 2023
Using iPSC and gene editing technologies to generate immune-cloaked "off-the-shelf" allogeneic ...
February 12, 2024
Our team returned from Advanced Therapies Week 2024 in Miami energized and excited about the ...
November 8, 2023
The ESCGT 30th Annual Congress was once again filled with the pioneering research and idea ...
August 2, 2023
The future of stem cell research starts here, at the ISSCR Annual Meeting, where more than ...
Introduction The manufacture of Advanced Therapy Medicinal Products (ATMPs) requires the ...
February 14, 2025
Precise gene editing is crucial for the development of cell-based therapies, particularly ...
Induced pluripotent stem cell (iPSC)-derived allogeneic cell therapies hold significant ...
July 18, 2023
Editor's note: In this installment of Expert Opinion, Suzanne Snellenberg, PhD, Director of ...
March 30, 2023
As published in Drug Target Review - March/April 2023 Issue Drug Target Review connects with ...
January 30, 2023
How has the cell therapy landscape evolved in the past ten years, particularly in regard to ...
December 8, 2023
"Cracking the genetic engineering for cell therapy case will enable us to start thinking about ...
September 21, 2023
"We're in an exciting age: the tools and techniques we now have open up the field of cell ...
August 3, 2023
"The future promise of allogeneic cell therapies"
October 24, 2024
Discover how transitioning to iPSC-based allogeneic cell therapies can revolutionize modern ...
June 18, 2024
"Cellistic offers therapeutic developers a new path towards iPSC allogeneic cell therapy ...